Form 8-K - Current report:
SEC Accession No. 0000914475-25-000186
Filing Date
2025-11-24
Accepted
2025-11-24 16:02:50
Documents
18
Period of Report
2025-11-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nbix-20251121.htm   iXBRL 8-K 23867
2 EX-10.1 exhibit101.htm EX-10.1 8838
6 GRAPHIC exhibit101001.jpg GRAPHIC 216306
7 GRAPHIC exhibit101002.jpg GRAPHIC 243347
8 GRAPHIC exhibit101003.jpg GRAPHIC 120081
9 GRAPHIC exhibit101004.jpg GRAPHIC 45735
10 GRAPHIC nbix-20251121_g1.jpg GRAPHIC 18386
  Complete submission text file 0000914475-25-000186.txt   1063313

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nbix-20251121.xsd EX-101.SCH 1791
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nbix-20251121_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nbix-20251121_pre.xml EX-101.PRE 12514
20 EXTRACTED XBRL INSTANCE DOCUMENT nbix-20251121_htm.xml XML 2716
Mailing Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130
Business Address 6027 EDGEWOOD BEND COURT SAN DIEGO CA 92130 (858) 617-7600
NEUROCRINE BIOSCIENCES INC (Filer) CIK: 0000914475 (see all company filings)

EIN.: 330525145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22705 | Film No.: 251512822
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)